• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素转换酶2(ACE2)缺乏通过其在调节脂质代谢中的作用加重肥胖相关肾小球病。

ACE2 deficiency exacerbates obesity-related glomerulopathy through its role in regulating lipid metabolism.

作者信息

Chen Yin-Yin, Hong Han, Lei Yu-Ting, Zou Jia, Yang Yi-Ya, He Li-Yu

机构信息

Department of Nephrology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha Clinical Research Center for Kidney Disease, Hunan Clinical Research Center for Chronic Kidney Disease, Changsha, 410000, Hunan Province, P. R. China.

Department of Nephrology, The Second Xiangya Hospital of Central South University, Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, 410011, Hunan Province, P. R. China.

出版信息

Cell Death Discov. 2022 Sep 30;8(1):401. doi: 10.1038/s41420-022-01191-2.

DOI:10.1038/s41420-022-01191-2
PMID:36180463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9523180/
Abstract

Obesity-related glomerulopathy is a secondary glomerular disease and its incidence has been increased globally in parallel with the obesity epidemic. ORG emerged as a growing cause of end-stage renal disease in recent years. Unbalanced production of adipokines at the adipose tissue as well as low-grade inflammatory processes play central roles in ORG progression. ORG mouse model with ACE2-knockout was generated and kidney injury was evaluated by biochemistry and histological staining assays. Protein and mRNA expressions were quantified by ELISA, western blot or qRT-PCR methods. ACE2 deficiency aggravated ORG-related renal injuries and stimulated both lipid accumulation and inflammatory responses. Further, Nrf2 pathway was deactivated upon ACE2-knockout. By contrast, ACE2 overexpression reactivated Nrf2 pathway and ameliorated ORG symptoms by decreasing fat deposition and reducing inflammatory responses. Our data demonstrated that ACE2 exerted the beneficial effects by acting through Nrf2 signaling pathway, suggesting the protective role of ACE2 against lipid accumulation and inflammatory responses in ORG pathogenesis.

摘要

肥胖相关肾小球病是一种继发性肾小球疾病,其发病率在全球范围内随着肥胖流行而上升。近年来,肥胖相关肾小球病已成为终末期肾病的一个日益重要的病因。脂肪组织中脂肪因子的产生失衡以及低度炎症过程在肥胖相关肾小球病的进展中起核心作用。构建了ACE2基因敲除的肥胖相关肾小球病小鼠模型,并通过生化和组织学染色分析评估肾损伤。通过ELISA、蛋白质印迹或qRT-PCR方法对蛋白质和mRNA表达进行定量分析。ACE2缺乏加重了肥胖相关肾小球病相关的肾损伤,并刺激了脂质积累和炎症反应。此外,ACE2基因敲除后Nrf2通路失活。相比之下,ACE2过表达可重新激活Nrf2通路,并通过减少脂肪沉积和减轻炎症反应来改善肥胖相关肾小球病症状。我们的数据表明,ACE2通过Nrf2信号通路发挥有益作用,提示ACE2在肥胖相关肾小球病发病机制中对脂质积累和炎症反应具有保护作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfdf/9525667/1ac29cd35f01/41420_2022_1191_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfdf/9525667/09d6dcfaa7b7/41420_2022_1191_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfdf/9525667/5360190ff135/41420_2022_1191_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfdf/9525667/1eb9ab742ab5/41420_2022_1191_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfdf/9525667/de0ddc35d772/41420_2022_1191_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfdf/9525667/1ac29cd35f01/41420_2022_1191_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfdf/9525667/09d6dcfaa7b7/41420_2022_1191_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfdf/9525667/5360190ff135/41420_2022_1191_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfdf/9525667/1eb9ab742ab5/41420_2022_1191_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfdf/9525667/de0ddc35d772/41420_2022_1191_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfdf/9525667/1ac29cd35f01/41420_2022_1191_Fig5_HTML.jpg

相似文献

1
ACE2 deficiency exacerbates obesity-related glomerulopathy through its role in regulating lipid metabolism.血管紧张素转换酶2(ACE2)缺乏通过其在调节脂质代谢中的作用加重肥胖相关肾小球病。
Cell Death Discov. 2022 Sep 30;8(1):401. doi: 10.1038/s41420-022-01191-2.
2
Wen-Shen-Jian-Pi-Hua-Tan decoction protects against early obesity-related glomerulopathy by improving renal bile acid composition and suppressing lipogenesis, inflammation, and fibrosis.稳肾健脾化痰汤通过改善肾脏胆汁酸组成、抑制脂生成、炎症和纤维化来预防早期肥胖相关性肾小球病。
Phytomedicine. 2023 Jul 25;116:154861. doi: 10.1016/j.phymed.2023.154861. Epub 2023 May 4.
3
Coptidis Rhizoma inhibits NLRP3 inflammasome activation and alleviates renal damage in early obesity-related glomerulopathy.黄连抑制 NLRP3 炎性小体激活并减轻肥胖相关性肾小球病早期的肾脏损伤。
Phytomedicine. 2018 Oct 1;49:52-65. doi: 10.1016/j.phymed.2018.05.019. Epub 2018 Jun 7.
4
CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy.CD36 介导的脂质积累和 NLRP3 炎性小体的激活导致肥胖相关性肾小球病中的足细胞损伤。
Mediators Inflamm. 2019 Apr 11;2019:3172647. doi: 10.1155/2019/3172647. eCollection 2019.
5
Targeting Renal Proximal Tubule Cells in Obesity-Related Glomerulopathy.靶向肥胖相关性肾小球病中的肾近端小管细胞
Pharmaceuticals (Basel). 2023 Sep 5;16(9):1256. doi: 10.3390/ph16091256.
6
Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples.肥胖相关性肾小球病:来自肾活检样本肾小球基因表达谱的见解
Endocrinology. 2006 Jan;147(1):44-50. doi: 10.1210/en.2005-0641. Epub 2005 Oct 6.
7
Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.血管紧张素转换酶2的缺失通过调节nephrin和肿瘤坏死因子-α-肿瘤坏死因子受体超家族成员1A信号通路,加剧载脂蛋白E缺陷小鼠的肾脏炎症和损伤。
J Transl Med. 2015 Aug 6;13:255. doi: 10.1186/s12967-015-0616-8.
8
Obesity-related glomerulopathy: Current approaches and future perspectives.肥胖相关性肾小球病:当前的方法和未来的展望。
Obes Rev. 2022 Jul;23(7):e13450. doi: 10.1111/obr.13450. Epub 2022 Apr 1.
9
Obesity-Related Glomerulopathy: A Latent Change in Obesity Requiring More Attention.肥胖相关性肾小球病:肥胖中的一种潜在变化,需要更多关注。
Kidney Blood Press Res. 2020;45(4):510-522. doi: 10.1159/000507784. Epub 2020 Jun 4.
10
Correction: ACE2 deficiency exacerbates obesity-related glomerulopathy through its role in regulating lipid metabolism.更正:血管紧张素转换酶2(ACE2)缺乏通过其在调节脂质代谢中的作用加剧肥胖相关的肾小球病。
Cell Death Discov. 2023 Oct 23;9(1):389. doi: 10.1038/s41420-023-01683-9.

引用本文的文献

1
Ace2 mutation disrupts amino acid absorption, impairs growth, and alters microbiota dynamics in zebrafish.Ace2突变会破坏斑马鱼的氨基酸吸收,损害其生长,并改变微生物群动态。
Commun Biol. 2025 Aug 14;8(1):1226. doi: 10.1038/s42003-025-08626-3.
2
ACE2 deficiency protects against heme protein-induced acute kidney injury.血管紧张素转换酶2缺乏可预防血红素蛋白诱导的急性肾损伤。
Am J Physiol Renal Physiol. 2025 May 1;328(5):F676-F683. doi: 10.1152/ajprenal.00061.2025. Epub 2025 Mar 25.
3
Novel insights into the central protective role of ACE2 in diabetic cardiomyopathy: from underlying signaling pathways to therapeutic perspectives.

本文引用的文献

1
IκB kinase promotes Nrf2 ubiquitination and degradation by phosphorylating cylindromatosis, aggravating oxidative stress injury in obesity-related nephropathy.IKK 激酶通过磷酸化圆柱瘤蛋白促进 Nrf2 的泛素化和降解,加剧肥胖相关性肾病中的氧化应激损伤。
Mol Med. 2021 Oct 28;27(1):137. doi: 10.1186/s10020-021-00398-w.
2
Overexpression of Central ACE2 (Angiotensin-Converting Enzyme 2) Attenuates the Pressor Response to Chronic Central Infusion of Ang II (Angiotensin II): A Potential Role for Nrf2 (Nuclear Factor [Erythroid-Derived 2]-Like 2).中枢 ACE2(血管紧张素转换酶 2)过表达可减轻慢性中枢输注 Ang II(血管紧张素 II)的升压反应:Nrf2(核因子 [红细胞衍生 2]样 2)的潜在作用。
Hypertension. 2020 Nov;76(5):1514-1525. doi: 10.1161/HYPERTENSIONAHA.120.15681. Epub 2020 Sep 8.
3
血管紧张素转换酶2(ACE2)在糖尿病性心肌病中的核心保护作用新见解:从潜在信号通路到治疗前景
Mol Cell Biochem. 2025 Jun;480(6):3535-3551. doi: 10.1007/s11010-024-05196-6. Epub 2025 Feb 10.
4
Targeting Renal Proximal Tubule Cells in Obesity-Related Glomerulopathy.靶向肥胖相关性肾小球病中的肾近端小管细胞
Pharmaceuticals (Basel). 2023 Sep 5;16(9):1256. doi: 10.3390/ph16091256.
Obesity-Related Glomerulopathy: A Latent Change in Obesity Requiring More Attention.肥胖相关性肾小球病:肥胖中的一种潜在变化,需要更多关注。
Kidney Blood Press Res. 2020;45(4):510-522. doi: 10.1159/000507784. Epub 2020 Jun 4.
4
Liraglutide Attenuates Non-Alcoholic Fatty Liver Disease in Mice by Regulating the Local Renin-Angiotensin System.利拉鲁肽通过调节局部肾素-血管紧张素系统减轻小鼠非酒精性脂肪性肝病
Front Pharmacol. 2020 Apr 8;11:432. doi: 10.3389/fphar.2020.00432. eCollection 2020.
5
OIP5-AS1 Attenuates Microangiopathy in Diabetic Mouse by Regulating miR-200b/ACE2.OIP5-AS1通过调控miR-200b/ACE2减轻糖尿病小鼠的微血管病变。
World Neurosurg. 2020 Jul;139:e52-e60. doi: 10.1016/j.wneu.2020.03.063. Epub 2020 Mar 19.
6
Mesenchymal stem cells modified with angiotensin-converting enzyme 2 are superior for amelioration of glomerular fibrosis in diabetic nephropathy.血管紧张素转换酶 2 修饰的间充质干细胞改善糖尿病肾病肾小球纤维化的作用更优。
Diabetes Res Clin Pract. 2020 Apr;162:108093. doi: 10.1016/j.diabres.2020.108093. Epub 2020 Feb 25.
7
The Role of Akt2 in the Protective Effect of Fenofibrate against Diabetic Nephropathy.Akt2 在非诺贝特防治糖尿病肾病中的作用。
Int J Biol Sci. 2020 Jan 1;16(4):553-567. doi: 10.7150/ijbs.40643. eCollection 2020.
8
Angiotensin-converting enzyme 2 regulates endoplasmic reticulum stress and mitochondrial function to preserve skeletal muscle lipid metabolism.血管紧张素转换酶 2 通过调节内质网应激和线粒体功能来维持骨骼肌脂质代谢。
Lipids Health Dis. 2019 Nov 27;18(1):207. doi: 10.1186/s12944-019-1145-x.
9
The inhibition of Nrf2 accelerates renal lipid deposition through suppressing the ACSL1 expression in obesity-related nephropathy.Nrf2 的抑制通过抑制肥胖相关性肾病中 ACSL1 的表达加速肾脏脂质沉积。
Ren Fail. 2019 Nov;41(1):821-831. doi: 10.1080/0886022X.2019.1655450.
10
Obesity: unrecognised or avoided? We are missing opportunities to 'make every contact count'.
Arch Dis Child. 2020 Mar;105(3):310-311. doi: 10.1136/archdischild-2019-317734. Epub 2019 Aug 16.